Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Engert

Showing results (21-30 of 173) with videos related to

Pageof 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
New drugs in the treatment of Hodgkin's diseaseP Borchmann, R Schnell, V Diehl, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1997
Idarubicin: a brief overview on pharmacology and clinical useP Borchmann, K Hübel, R Schnell, et al.
The Cochrane Database of Systematic Reviews|July 22, 2004
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaJ Bohlius, M Reiser, G Schwarzer, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Non-Hodgkin's Lymphoma: A Review of Immunotherapeutic Approaches to TreatmentR Schnell, S Barth, V Diehl, et al.
The Cochrane Database of Systematic Reviews|January 10, 2003
Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphomaJ Bohlius, M Reiser, G Schwarzer, et al.
Cancer Genetics and Cytogenetics|June 1, 1987
Translocation (6;9)(p23;q34) in smoldering leukemia and acute nonlymphocytic leukemiaC Fonatsch, B Stollmann, J Holldack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Current strategies of antibody-based treatment in Hodgkin's diseaseR Schnell, P Borchmann, H Schulz, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 18, 1998
[Pathogenesis and therapy of Hodgkin lymphoma]H Tesch, H Bohlen, J Wolf, et al.
Onkologie|September 16, 2003
Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: experience with two cases and review of the literatureH Pels, H Schulz, U Schlegel, et al.
The Cochrane Database of Systematic Reviews|February 20, 2004
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaJ Bohlius, M Reiser, G Schwarzer, et al.
Pageof 18

Showing results (21-30 of 173) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
New drugs in the treatment of Hodgkin's diseaseP Borchmann, R Schnell, V Diehl, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1997
Idarubicin: a brief overview on pharmacology and clinical useP Borchmann, K Hübel, R Schnell, et al.
The Cochrane Database of Systematic Reviews|July 22, 2004
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaJ Bohlius, M Reiser, G Schwarzer, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Non-Hodgkin's Lymphoma: A Review of Immunotherapeutic Approaches to TreatmentR Schnell, S Barth, V Diehl, et al.
The Cochrane Database of Systematic Reviews|January 10, 2003
Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphomaJ Bohlius, M Reiser, G Schwarzer, et al.
Cancer Genetics and Cytogenetics|June 1, 1987
Translocation (6;9)(p23;q34) in smoldering leukemia and acute nonlymphocytic leukemiaC Fonatsch, B Stollmann, J Holldack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Current strategies of antibody-based treatment in Hodgkin's diseaseR Schnell, P Borchmann, H Schulz, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 18, 1998
[Pathogenesis and therapy of Hodgkin lymphoma]H Tesch, H Bohlen, J Wolf, et al.
Onkologie|September 16, 2003
Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: experience with two cases and review of the literatureH Pels, H Schulz, U Schlegel, et al.
The Cochrane Database of Systematic Reviews|February 20, 2004
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaJ Bohlius, M Reiser, G Schwarzer, et al.
Pageof 18